Description
CUDC-907isaninhibitorofPI3KandclassIandIIhistonedeacetylases(HDACs).Thiscompoundexhibitsanticancerchemotherapeuticactivity,inhibitingcellproliferationandtumorgrowthinavarietyofcancermodels.
CUDC-907isaninhibitorofPI3KandclassIandIIhistonedeacetylases(HDACs).Thiscompoundexhibitsanticancerchemotherapeuticactivity,inhibitingcellproliferationandtumorgrowthinavarietyofcancermodels.
| CasNo. | 1339928-25-4 |
|---|---|
| Purity | ≥98% |
| Formula | C23H24N8O4S |
| FormulaWt. | 508.55 |
| IUPACName | N-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide |
| Appearance | WhiteCrystalPowder |
| StoreTemp | -20°C |
|---|---|
| ShipTemp | Ambient |
| MSDS | C8112MSDSPDF |
|---|---|
| InfoSheet | C8112InfoSheetPDF |
QianC,LaiCJ,BaoR,etal.Cancernetworkdisruptionbyasinglemoleculeinhibitortargetingbothhistonedeacetylaseactivityandphosphatidylinositol3-kinasesignaling.ClinCancerRes.2012Aug1;18(15):4104-13.PMID:22693356.